BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 12043934)

  • 1. Diagnostic value of fasting capillary glucose, fructosamine and glycosylated haemoglobin in detecting diabetes and other glucose tolerance abnormalities compared to oral glucose tolerance test.
    Herdzik E; Safranow K; Ciechanowski K
    Acta Diabetol; 2002 Apr; 39(1):15-22. PubMed ID: 12043934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
    Gołembiewska E
    Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative indices of glucose homeostasis as biochemical diagnostic tests for abnormal glucose tolerance in an African setting.
    Kengne AP; Erasmus RT; Levitt NS; Matsha TE
    Prim Care Diabetes; 2017 Apr; 11(2):119-131. PubMed ID: 28132763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of ADA and WHO diagnostic criteria for diabetes diagnosis and other categories of glucose intolerance ].
    Herdzik E; Safranow K; Ciechanowski K; Byra E; Gołdyn U
    Pol Merkur Lekarski; 2002 Oct; 13(76):316-20. PubMed ID: 12557440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA; Al-Naemi AH
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
    Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
    Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.
    Valderhaug TG; Jenssen T; Hartmann A; Midtvedt K; Holdaas H; Reisaeter AV; Hjelmesaeth J
    Transplantation; 2009 Aug; 88(3):429-34. PubMed ID: 19667949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Accuracies of Glycated Hemoglobin, Fructosamine, and Homeostasis Model Assessment of Insulin Resistance in Predicting Impaired Fasting Glucose, Impaired Glucose Tolerance, or New Onset Diabetes After Transplantation.
    Rosettenstein K; Viecelli A; Yong K; Nguyen HD; Chakera A; Chan D; Dogra G; Lim EM; Wong G; Lim WH
    Transplantation; 2016 Jul; 100(7):1571-9. PubMed ID: 26437275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of HbA1 and fructosamine in predicting impaired glucose tolerance--an alternative to OGTT to detect diabetes mellitus or gestational diabetes.
    Salemans TH; van Dieijen-Visser MP; Brombacher PJ
    Ann Clin Biochem; 1987 Sep; 24 ( Pt 5)():447-52. PubMed ID: 3662394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population.
    Ko GT; Chan JC; Woo J; Cockram CS
    Diabetes Care; 1998 Dec; 21(12):2094-7. PubMed ID: 9839099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 1-hour post-load glucose level is more effective than HbA1c for screening dysglycemia.
    Jagannathan R; Sevick MA; Fink D; Dankner R; Chetrit A; Roth J; Buysschaert M; Bergman M
    Acta Diabetol; 2016 Aug; 53(4):543-50. PubMed ID: 26794497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients.
    Thewjitcharoen Y; Jones Elizabeth A; Butadej S; Nakasatien S; Chotwanvirat P; Wanothayaroj E; Krittiyawong S; Himathongkam T; Himathongkam T
    BMC Endocr Disord; 2019 Feb; 19(1):23. PubMed ID: 30770743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of glycosylated haemoglobin as an index of glucose intolerance.
    Snehalatha C; Ramachandran A; Satyavani K; Vijay V
    Diabetes Res Clin Pract; 2000 Feb; 47(2):129-33. PubMed ID: 10670913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can HbA1c replace OGTT for the diagnosis of diabetes mellitus among Chinese patients with impaired fasting glucose?
    Yu EY; Wong CK; Ho SY; Wong SY; Lam CL
    Fam Pract; 2015 Dec; 32(6):631-8. PubMed ID: 26467644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China.
    Zhou X; Pang Z; Gao W; Wang S; Zhang L; Ning F; Qiao Q
    Diabetes Care; 2010 Mar; 33(3):545-50. PubMed ID: 20007941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does HbA1C predict isolated impaired fasting glycaemia in the oral glucose tolerance test in subjects with impaired fasting glycaemia?
    Likhari T; Aulakh TS; Singh BM; Gama R
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):418-20. PubMed ID: 18583629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of methods for detecting glycemic disorders.
    Bergman M; Abdul-Ghani M; DeFronzo RA; Manco M; Sesti G; Fiorentino TV; Ceriello A; Rhee M; Phillips LS; Chung S; Cravalho C; Jagannathan R; Monnier L; Colette C; Owens D; Bianchi C; Del Prato S; Monteiro MP; Neves JS; Medina JL; Macedo MP; Ribeiro RT; Filipe Raposo J; Dorcely B; Ibrahim N; Buysschaert M
    Diabetes Res Clin Pract; 2020 Jul; 165():108233. PubMed ID: 32497744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening.
    Tsuji I; Nakamoto K; Hasegawa T; Hisashige A; Inawashiro H; Fukao A; Hisamichi S
    Diabetes Care; 1991 Nov; 14(11):1075-7. PubMed ID: 1797489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.